Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SC599 Vaccine for Shigella Dysenteriae 1
NCT00210288Phase 2Completed
- Sponsor
- Institut Pasteur
- Start
- May 2005
- Primary completion
- Sep 2006
- Modality
- Live Attenuated Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of SC599 in shigellosis, sponsored by Institut Pasteur. Started May 2005; status: completed.
02
Drugs
SC599
03
Conditions
shigellosis
Beyond the preview
Go deeper on NCT00210288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210288.